Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Pilocarpine in Chronic Angle-Closure Glaucoma
NCT00762645Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2007
- Primary completion
- May 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 4 trial of travoprost in chronic angle-closure glaucoma (CACG), sponsored by Alcon Inc.. Started Feb 2007; status: completed.
02
Drugs
travoprost
03
Conditions
chronic angle-closure glaucoma (CACG)
Beyond the preview
Go deeper on NCT00762645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762645.